Related references
Note: Only part of the references are listed.Toward Precision Radiotherapy for Use with Immune Checkpoint Blockers
Claire Vanpouille-Box et al.
CLINICAL CANCER RESEARCH (2018)
Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma
Paul Nghiem et al.
FUTURE ONCOLOGY (2017)
Novel Opportunities to Use Radiation Therapy with Immune Checkpoint Inhibitors for Melanoma Management
Kamran A. Ahmed et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2017)
Barriers to Radiation-induced In Situ Tumor vaccination
Erik Wennerberg et al.
FRONTIERS IN IMMUNOLOGY (2017)
Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas
Natalie Vandeven et al.
IMMUNOTHERAPY (2016)
A Prospective Clinical Trial Combining Radiation Therapy With Systemic Immunotherapy in Metastatic Melanoma
Susan M. Hiniker et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab
F. Stephen Hodi et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert et al.
LANCET ONCOLOGY (2016)
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
Paul T. Nghiem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Merkel Cell Carcinoma: An Unusually Immunogenic Cancer Proves Ripe for Immune Therapy
Natalie A. Vandeven et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant
Kobe Reynders et al.
CANCER TREATMENT REVIEWS (2015)
Pseudoprogression and Immune-Related Response in Solid Tumors
Victoria L. Chiou et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Single-fraction radiation therapy in patients with metastatic Merkel cell carcinoma
Jayasri G. Iyer et al.
CANCER MEDICINE (2015)
Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8+ T cells
Joanne Y. H. Lim et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy
Antonio M. Grimaldi et al.
ONCOIMMUNOLOGY (2014)
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Eric A. Reits et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Share Paper
